NEXGEL (NXGL) Set to Announce Quarterly Earnings on Monday

NEXGEL (NASDAQ:NXGL – Get Free Report) is set to announce its earnings results after the market closes on Monday, August 14th. Investors that are interested in registering for the company’s conference call can do so using this link.

NEXGEL (NASDAQ:NXGL – Get Free Report) last announced its quarterly earnings results on Monday, May 15th. The company reported ($0.15) earnings per share (EPS) for the quarter. NEXGEL had a negative net margin of 163.84% and a negative return on equity of 45.75%. The business had revenue of $0.62 million during the quarter.

Get NEXGEL alerts:

NEXGEL Stock Up 3.3 %

Shares of NASDAQ NXGL opened at $1.88 on Friday. NEXGEL has a 12-month low of $1.09 and a 12-month high of $3.05. The company has a market capitalization of $10.55 million, a PE ratio of -2.81 and a beta of 0.40. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.78 and a quick ratio of 4.15. The firm’s 50-day moving average is $2.36 and its two-hundred day moving average is $1.85.

Hedge Funds Weigh In On NEXGEL

A hedge fund recently bought a new stake in NEXGEL stock. Renaissance Technologies LLC acquired a new stake in NEXGEL, Inc. (NASDAQ:NXGL – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 20,231 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned about 0.36% of NEXGEL at the end of the most recent reporting period. 1.52% of the stock is currently owned by hedge funds and other institutional investors.

About NEXGEL

(Get Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Read More

• Five stocks we like better than NEXGEL
• The Dividend Kings With Highest Yield
• Investing in Coffee: 3 Great Strategies to Consider
• What to Know About Investing in Penny Stocks
• 5 Best Stocks to Buy in a Bear Market
• What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
• 3 Pharmaceutical Stocks to Buy and Hold for the Long Haul

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.